The Information Machine
Concluded·following since 18 Aug 2026·Day 3·3 sources·updated 19 Aug 2026

Claude autonomous protein binder experiment

The gist

Claude designed validated protein binders for 14 of 15 drug targets at 26.8% hit rate

Designing molecules that bind tightly to drug targets traditionally requires weeks or months of expert work per target. These results show an AI system autonomously completing that step with independently validated wet-lab results competitive with human-led efforts.

The full picture

Anthropic tested whether Claude could autonomously design protein binders from scratch. Given a protocol written by a human expert, Claude handled the full computational pipeline, covering target research, tool installation, candidate generation, filtering, and final selection, without human intervention on individual design decisions. Adaptyv Bio and Twist Bioscience independently synthesized and tested the resulting proteins, finding 354 of 1,320 measured designs bound their intended targets, a 26.8% hit rate, with Claude producing binders for 14 of 15 targets. On 4 of 6 targets comparable to human-led open design competitions, Claude achieved higher hit rates. A Mythos Preview model, given a dedicated 24-hour campaign per target rather than a shared 48-hour campaign across targets, reached a 35.1% hit rate. One identified limitation is that Claude cannot reliably detect when an entire campaign has failed; unsuccessful targets sometimes received computational scores similar to successful ones.

How it developed
20 August 2026

Newsletter coverage confirms Anthropic published a formal report on Claude's drug discovery applications

19 August 2026

Anthropic published results on August 18 showing that Claude, following a protocol written by a human expert, autonomously ran the full computational steps of a protein-design campaign, including target research, tool installation, candidate generation, and final selection, without human decisions on individual designs.

Adaptyv Bio and Twist Bioscience independently built and tested the resulting proteins, finding 354 of 1,320 designs bound their intended targets, a 26.8% hit rate, with Claude producing at least one successful binder for 14 of 15 targets. On 4 of 6 targets comparable to human-led open design competitions, Claude achieved higher hit rates; a Mythos Preview model given a dedicated 24-hour per-target campaign reached 35.1%. One identified limitation: Claude cannot reliably detect when an entire campaign has failed, as unsuccessful targets sometimes received computational scores similar to successful ones.

18 August 2026

Details published: 354 of 1,320 measured designs bound targets; Mythos Preview model reached 35.1% hit rate with dedicated per-target campaigns

Sources
The daily email

Want this in your inbox?

I send a short email each morning with the stories that moved. If you would rather just read here, that works too.

Subscribe free